This project is directed toward the identification and analysis of the genes affecting the differential susceptibility of different mouse strains to Theiler's murine encephalomyelitis virus (TMEV)- induced demyelinating disease. TMEV-induced demyelinating disease provides an excellent model for human multiple sclerosis (MS), both at a level of clinical symptoms and of histopathology. The disease occurs as the result of an active cell-mediated immune response, probably delayed type hypersensitivity, against the virus which results in """"""""innocent bystander"""""""" destruction of myelin. Like human MS, there is a clear genetic influence of disease development, and the identification/analysis of the involved genes may provide clues as to mechanisms (including prevention or alleviation) and genetic risk factors. These will be especially relevant where the equivalent human genes are known which correlate which those defined in these studies. The analysis will proceed along three lines of inquiry. The first is the use of classical methods of genetic analysis, involving the generation and study of Fl and F2 hybirds and backcross progeny between susceptible and resistant strains in order to determine whether susceptibility is a dominant or recessive trait and to make a minimal estimate of the number of genes involved. Subsequent use of appropriate congenic, recombinant, mutant and recombinant-inbred strains will permit the identification and mapping of specific loci. The second phase is to analyse whether resistance to disease occurs (at passively, because the resistant animals lack the immunological """"""""machinery"""""""" to carry out the destructive immune response or (b) because they have active mechanisms for preventing the destructive response. These will be analyzed by experiments involving cell transfers between susceptible and resistant animals, and by the use of reagents which affect inhibitory mechanisms such as suppressor T lymphocytes. The third phase will be the analysis of the immune response genetics of resistant and susceptible mouse strains against various viral capsid proteins. We hope to determine if there are particular proteins or epitopes which are differentially recognized by susceptible and resistant strains, and to identify the genes involved in such differential immune responsiveness.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Ifergan, Igal; Davidson, Todd S; Kebir, Hania et al. (2017) Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. J Autoimmun 84:1-11
Jeong, Su Ji; Cooper, John G; Ifergan, Igal et al. (2017) Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice. Neurobiol Dis 108:73-82
Richards, Maureen H; Getts, Meghann Teague; Podojil, Joseph R et al. (2011) Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J Autoimmun 36:142-54
Jin, Young-Hee; Kang, Hyun Seok; Mohindru, Mani et al. (2011) Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 mice. J Virol 85:3033-40
Kang, Hyun Seok; Kim, Byung S (2010) Predominant clonal accumulation of CD8+ T cells with moderate avidity in the central nervous systems of Theiler's virus-infected C57BL/6 mice. J Virol 84:2774-86
Getts, Meghann Teague; Richards, Maureen H; Miller, Stephen D (2010) A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice. Virology 402:102-11
Son, Kyung-No; Pugazhenthi, Subbiah; Lipton, Howard L (2009) Activation of tumor suppressor protein p53 is required for Theiler's murine encephalomyelitis virus-induced apoptosis in M1-D macrophages. J Virol 83:10770-7
Ercolini, A M; Miller, S D (2009) The role of infections in autoimmune disease. Clin Exp Immunol 155:1-15
Münz, Christian; Lünemann, Jan D; Getts, Meghann Teague et al. (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246-58
Olson, Julie K; Miller, Stephen D (2009) The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. J Immunol 182:5712-22

Showing the most recent 10 out of 128 publications